State of New Jersey Common Pension Fund D’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$54.6M Sell
1,943,131
-22,286
-1% -$593K 0.21% 79
2025
Q4
$48.9M Sell
1,965,417
-10,906
-0.6% -$275K 0.18% 98
2025
Q3
$50.4M Buy
1,976,323
+68,293
+4% +$1.69M 0.19% 94
2025
Q2
$46.3M Sell
1,908,030
-2,274
-0.1% -$53K 0.18% 96
2025
Q1
$48.4M Sell
1,910,304
-178,521
-9% -$4.67M 0.22% 83
2024
Q4
$55.4M Hold
2,088,825
0.22% 78
2024
Q3
$60.5M Hold
2,088,825
0.25% 74
2024
Q2
$58.4M Sell
2,088,825
-1,120,550
-35% -$30.9M 0.26% 65
2024
Q1
$89.1M Hold
3,209,375
0.27% 64
2023
Q4
$92.4M Hold
3,209,375
0.31% 53
2023
Q3
$106M Sell
3,209,375
-101,404
-3% -$3.59M 0.38% 44
2023
Q2
$121M Hold
3,310,779
0.41% 40
2023
Q1
$135M Buy
3,310,779
+9,521
+0.3% +$411K 0.48% 34
2022
Q4
$169M Buy
3,301,258
+10,427
+0.3% +$500K 0.64% 25
2022
Q3
$144M Buy
3,290,831
+5,419
+0.2% +$263K 0.58% 26
2022
Q2
$172M Sell
3,285,412
-17,015
-0.5% -$867K 0.65% 23
2022
Q1
$171M Buy
3,302,427
+10,455
+0.3% +$542K 0.54% 29
2021
Q4
$194M Sell
3,291,972
-9,030
-0.3% -$447K 0.56% 27
2021
Q3
$142M Sell
3,301,002
-2,594
-0.1% -$115K 0.44% 35
2021
Q2
$129M Buy
3,303,596
+1,103
+0% +$42.9K 0.42% 33
2021
Q1
$120M Sell
3,302,493
-174,635
-5% -$6.2M 0.42% 35
2020
Q4
$128M Sell
3,477,128
-363,953
-9% -$13.3M 0.45% 35
2020
Q3
$134M Sell
3,841,081
-165,629
-4% -$5.81M 0.53% 29
2020
Q2
$124M Sell
4,006,710
-248,496
-6% -$8.44M 0.52% 32
2020
Q1
$132M Hold
4,255,206
0.64% 23
2019
Q4
$158M Sell
4,255,206
-262,343
-6% -$9.34M 0.6% 28
2019
Q3
$154M Sell
4,517,549
-14,651
-0.3% -$533K 0.59% 31
2019
Q2
$186M Sell
4,532,200
-105,400
-2% -$4.19M 0.69% 24
2019
Q1
$187M Buy
4,637,600
+155,743
+3% +$6.24M 0.7% 24
2018
Q4
$186M Sell
4,481,857
-1,069,810
-19% -$44.4M 0.79% 21
2018
Q3
$232M Sell
5,551,667
-284,580
-5% -$11M 0.86% 16
2018
Q2
$201M Buy
5,836,247
+316,200
+6% +$10.8M 0.76% 20
2018
Q1
$186M Buy
5,520,047
+316,200
+6% +$10.9M 0.72% 24
2017
Q4
$179M Sell
5,203,847
-168,640
-3% -$5.75M 0.68% 26
2017
Q3
$182M Buy
5,372,487
+210,800
+4% +$6.78M 0.73% 23
2017
Q2
$164M Sell
5,161,687
-121,210
-2% -$3.82M 0.68% 25
2017
Q1
$171M Sell
5,282,897
-486,948
-8% -$15.4M 0.72% 23
2016
Q4
$178M Sell
5,769,845
-173,910
-3% -$5.31M 0.76% 20
2016
Q3
$191M Buy
5,943,755
+181,288
+3% +$6.06M 0.82% 18
2016
Q2
$193M Sell
5,762,467
-1,386,010
-19% -$44.2M 0.87% 18
2016
Q1
$201M Sell
7,148,477
-569,160
-7% -$16.3M 0.91% 18
2015
Q4
$236M Sell
7,717,637
-279,310
-3% -$8.79M 1% 14
2015
Q3
$238M Sell
7,996,947
-1,069,810
-12% -$34.3M 1.01% 12
2015
Q2
$288M Sell
9,066,757
-121,210
-1% -$3.95M 1.11% 12
2015
Q1
$303M Sell
9,187,967
-210,800
-2% -$6.7M 1.18% 11
2014
Q4
$278M Hold
9,398,767
1.07% 12
2014
Q3
$264M Buy
9,398,767
+105,400
+1% +$2.96M 1.04% 12
2014
Q2
$262M Buy
+9,293,367
New +$265M 1.04% 13

Other funds holding PFE

State of New Jersey Common Pension Fund D's PFE Position: Q1 2026 in Review

State of New Jersey Common Pension Fund D reduced its Pfizer (PFE) stake by 1.1% in Q1 2026, selling an estimated $593K and leaving 1,943,131 shares worth $54.6M. The position accounts for 0.21% of the portfolio, ranked #79.

State of New Jersey Common Pension Fund D first reported a position in PFE in Q2 2014 and has held it in 48 quarters since. The position peaked at $303M in Q1 2015. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • State of New Jersey Common Pension Fund D held 1,943,131 shares of Pfizer worth $54.6M as of Q1 2026.
  • State of New Jersey Common Pension Fund D sold 22,286 Pfizer shares in Q1 2026, an estimated $593K.
  • Pfizer made up 0.21% of State of New Jersey Common Pension Fund D's portfolio in Q1 2026, its #79 holding.
  • State of New Jersey Common Pension Fund D first reported a position in Pfizer in Q2 2014 and has held it in 48 quarters since.
  • State of New Jersey Common Pension Fund D's Pfizer position peaked at $303M in Q1 2015.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q1 2026, filed 5 May 2026.